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Abstract
The gut-brain axis is a bidirectional pathway that acts as a connection between the gut
and the brain. Bacterial changes in the gut alter this pathway, affecting organism’s
health, cognition, and behavior. Commensal bacteria in the gut can reduce inflammation
and increase longevity while pathogenic bacteria can have opposite effects. Reduced
commensal gut bacteria can result in an increase in stress activation, depression, and
anxiety in both human and animal models. Increases in commensal bacteria and
decreases in pathobiontic bacteria can decrease hypothalamic pituitary adrenal (HPA)
system activation, anxious behavior, and depressive behavior. Alternatively, increases in
pathobionts can lead to decreases in neurogenesis, synaptogenesis, and synaptic
plasticity, and can be observed behaviorally through deficits in hippocampally-dependent
tasks. Therefore, changes to gut microflora diversity due to diet, age, antibiotic use, or
probiotic use can alter the functioning of the individual. Antibiotics reduce both harmful
and commensal gut microflora, which can lead to reduced hippocampal neurogenesis,
impaired spatial memory performance, and increased depressive-like behavior.
Administration of antibiotics can have long-term consequences following the cessation of
antibiotic treatment. Probiotics may rescue these effects by reinstating commensal gut
bacteria. As people age, a decrease in gastrointestinal tract functioning occurs, altering
the gut microbiome and resulting in decreased diversity of commensal bacteria and an
increased diversity of harmful bacteria. These effects are associated with reduced
cognitive performance. Antibiotic use also contributes to the loss of gut bacteria
diversity, and may augment cognitive-related deficits in older adults. The current study
examined the effects of antibiotic and probiotic administration on spatial memory
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performance and depression across two age groups in Long-Evans rats. Spatial memory
performance was assessed via object location task and depressive behavior was assessed
via forced swim test. Baseline spatial memory performance and depressive behavior
were compared to the same behaviors following antibiotic treatment and then again
following probiotic treatment. Antibiotic consumption predicted forced swim test
performance; however, no differences were observed between treatment groups and age.
Probiotic consumption did not predict behavioral performance. Although not expected,
results suggested that a possible dosage effect exists for the amount of treatment to yield
an effect.
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1
Running head: MICROBIOME, MEMORY, DEPRESSION, AND AGE
The Effects of Antibiotics and Probiotics on Memory and Depression Across Age Groups
Gut Microbiome Diversity
The primary purpose of gut microbiota is to extract nutrients from food eaten to
benefit both organism and host (Kau et al., 2012). Additionally, these microbes have the
ability to convert vitamins from food to byproducts, such as folate and cobalamin, which
has been hypothesized to have a downstream effect on DNA methylation, chromatin
structure, and gene transcription in the host (Kau et al., 2012). The ability of these
microbes shows that the presence of gut microbiota may be essential to the health and
survivability of the organism. Increased diversity in commensal strains, or beneficial
bacteria, (e.g., Bifidobacteria) have been linked to reduced inflammation and increased
longevity compared to individuals with lower commensal microflora diversity (Kato et
al., 2017; Biagi et al., 2012). However, an increase in diversity of pathobiontic bacteria,
organisms that originate as commensal bacteria that can become disease-causing over
time (e.g., Proteobacteria species), can promote inflammation (Biagi et al., 2010) by
triggering the innate immune system involved in the stress response (for review see
Guigoz et al., 2008). In this competition for gut real estate, two types of diversity have
been defined as important: gut species richness (i.e., the number of species present in the
system) and functional response diversity (i.e., a functionally similar microbe “fills in”
space created by the compromised former microbe); (Lozupone et al., 2013). Bacterial
eutrophication, or the excessive colonization of a single species, negatively impacts both
types of gut microbiome diversity because a single species overpopulates the area so that
other, functionally different microbes cannot be established. It is this decrease in
bacterial diversity that is linked to various disease states, including: obesity (Turnbaugh,
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Bäckhed, Fulton, & Gordon, 2008), inflammatory bowel disease (Willing et al., 2010),
and Clostridioides-difficile Associated Disease (Chang et al., 2008). Therefore, an
introduction of commensal bacteria may have beneficial effects on the organism while
continued existence of pathobiontic bacteria have long lasting, detrimental effects.
Increased pathobiontic species diversity can result in permeability of the gut as
the result of increased inflammation (for review see Guigoz et al., 2008; Biagi et al.,
2010). It has been proposed that adverse effects on an organism’s health are caused by
an increased permeability of the gut microbiome (for review see Guigoz et al., 2008), and
are associated with the development of Alzheimer’s Disease and other dementias (for
review see Jiang, Li, Huang, Liu, & Zhao, 2017). In addition to affecting the
permeability of the blood-brain barrier (BBB) (Braniste et al., 2015), increased
permeability of the gut microbiome is also associated with increased proinflammatory
cytokines (Biagi et al., 2010), diet (Claesson et a., 2011), mucosal adhesion (Ouwehand,
Isolauri, Krijavainen, & Salminen, 1999; He et al., 2001), and antibiotics (Ceylani,
Jakubowska-Dogru, Gurbanov, Teker, & Gozen, 2018; Leclercq et al., 2017; Moore &
O’Keeffe, 1999). The increased permeability of the gut microbiome (Guigoz et al., 2008)
has been hypothesized to subsequently trigger the inflammatory response, which, in turn,
causes an increased permeability of the BBB triggering neuroinflammation, leading to
neurodegeneration (for review see Quigley, 2017).
The importance of gut microbiome diversity is highlighted by studies examining
germ-free (GF) mice. Early establishment of the gut microbiome is essential for proper
development of the HPA axis, otherwise the system is not fully effective at suppressing
the stress response under non-stressful conditions (Sudo et al., 2004). Early life stress is
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linked to an increased permeability of the gut (Varghese et al., 2006), which allows
essential nutrients to leak out of the gut (Guigoz et al., 2008) and pathogens to enter
(Arrieta, Bistritz, & Meddings, 2006). This effect becomes especially problematic
because bacterial-mucosal adhesion that is essential for the effectiveness of commensal
bacterial strains decreases over time (Ouwehand, Isolauri, Krijavainen, & Salminen,
1999; He et al., 2001). Germ-free animals are often used to study the importance of gut
microbiome diversity in animal models by rearing them without any contact with
microorganisms. Therefore, they do not establish diverse microbiomes. Inducing stress
in GF animals resulted in memory impairments and increased blood serum
corticosterone, a hormone heavily involved in the stress response, compared to control
animals with an established microbiome (Gareau et al., 2011). These studies highlight
the importance of an established, diverse gut microbiome to serve as protection against
the adverse effects of inflammation.
Stress and the Microbiome
The gut microbiome and the HPA axis communicate bidirectionally. Therefore,
alterations to one system may result in alterations to the other system. Increased
commensal gut flora diversity has been shown to have protective factors against stress.
For example, using Bifidobacterium or Lactobacilli strains to establish the gut
microbiome in GF mice, effects of stress were significantly reduced compared to GF
animals with unestablished gut microbiomes (Sudo et al., 2004) and helped prevent the
emergence of pathogens that target the gut (e.g., irritable bowel syndrome; Bailey & Coe,
1999), respectively. Alternatively, subjecting an animal to chronic stress at a young age
can reduce the number of Lactobacilli present in the gut, which increased the likelihood
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of pathogenic bacterial infection (Bailey & Coe, 1999). Probiotic administration can
ameliorate these effects of stress (Eutamene & Bueno, 2007) by halting the reduction in
established Lactobacilli caused by maternal separation in animals (Gareau, Jury,
MacQueen, Sherman, & Perdue, 2007), effectively reducing corticosterone release in
response to stress compared to controls (for review see Sarkar et al., 2016). Importantly,
this evidence suggests that the administration of probiotics can reduce the activity of the
HPA axis, further protecting the organism from the negative impacts of stress. Taken
together, the observed effects of a diverse gut microbiome on stress reduction provide
further evidence of the link between the brain and the gut.
Microbiome Diversity on Neurogenesis
Stress has also been shown to have a negative impact on neural functioning, and
its effects can be exacerbated as the result of reduced gut microbiome diversity (Braniste
et al., 2015). In response to an alteration in gut microbiome composition, GF mice
exhibited a reduction in presynaptic neurotransmitter release and synaptophysin, a protein
essential for synaptogenesis (Kwon & Chapman, 2011; Tarsa & Goda, 2002) in the
striatum compared to control mice (for review see Tognini, 2017). In addition to
affecting the creation of new synapses, GF mice exhibit reduced PSD95, a protein
heavily involved in synaptic plasticity and maturation mice (Béïque & Andrade, 2003;
El-Husseini et al., 2000). Both synaptophysin and PSD95 are essential for maintaining
effective levels of neural activity in the brain. Without an established microbiome, new
synapses can neither be created nor beneficially altered as effectively as an organism with
an established gut microbiome, which has implications on how that organism learns new
information and subsequently integrates the new into preexisting information.
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Neurogenesis is the ability of the brain to produce new neurons. It occurs in the
subgranular zone of the dentate gyrus within the hippocampus (Kempermann, 2008) and
is the neural basis for learning and memory. Researchers found that neurogenesis in the
subgranular zone of the adult hippocampus is regulated by gut microbiota (Fung, Olson,
& Hsiao, 2017; Ogbonnaya et al., 2015). For example, researchers found that GF mice
had significantly fewer cells in the subventricular zone (SVZ), a brain region believed to
be the center for progenitor cells that guide neurodevelopment, compared to control mice
(Sawada et al., 2018). However, after housing GF mice with control mice for a month,
the number of new neurons in the SVZ was equivalent for both groups (Sawada et al.,
2018), suggesting not only that having an established microbiome is important for neural
progenation, but that the microbiome advantageously alter the brain later in development.
Although an increased gut microbiome diversity is generally recognized as imperative for
the health of the organism, an increased diversity of inflammation-causing pathobiontic
bacteria resulted in a reduction in neurogenesis compared to GF mice that had no
established gut microbiome (Luczynski et al., 2016). Therefore, the type of bacteria
colonizing the gut is as important as high bacterial diversity.
The diversity of the gut microbiome has also been observed to alter the
permeability of the BBB, in turn affecting the rate at which neurogenesis can occur
(Braniste et al., 2015). Specifically, preventing the permeability of the BBB was found to
promote neurogenesis, while increasing BBB permeability resulted in reduced
neurogenesis (Braniste et al., 2015). These effects are hypothesized to be driven by the
increased BBB permeability allowing glucocorticoids, a class of stress hormone, to then
enter the brain more readily, and reduce neurogenesis by reducing brain-derived
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neurotrophic factor (BDNF; Braniste et al., 2015). Reduced BDNF has been observed in
both the hippocampus and the cortex of GF animals compared to controls (Sudo et al.,
2004) as well as in adults that had their gut microbiota reduced during adolescence
(Desbonnet et al., 2015). In addition to a reduction in BDNF, NMDA receptor subunit,
NR2A, was also reduced in the hippocampus of GF mice compared to control mice (Sudo
et al., 2004). The effects of a reduced gut microbiome on fully functional NMDA
receptors demonstrate the importance of high commensal gut bacteria diversity, as these
receptors are essential for the initiation of long-term potentiation.
Microbiome Diversity on Memory
Long-term potentiation is the neural basis for learning and memory by
strengthening synaptic connection. Therefore, a reduction in NMDA receptors may
result in an impairment of memory consolidation and retrieval. Cryan and O’Mahony
(2011) argued that high diversity of commensal microflora is essential for improved
performance on both spatial and working memory tasks. These types of tasks are
hippocampally-dependent, and provide further evidence in support of observations made
regarding the relationship between gut flora diversity and neurogenesis. Germ-free mice
have exhibited memory deficits in non-spatial tasks, such as the novel object recognition
task, and working memory tasks, such as the T-maze (Gareau et al., 2011). Differences
in working memory and reference memory tasks, as measured by the hole-board test,
have been shown to be manipulated by diet (Claesson et al., 2012; Li, Dowd, Scurlock,
Acosta-Martinez, & Lyte, 2009), which largely effects gut microbiome diversity
(Claesson et a., 2011). Specifically, animals that received a standard pellet-based diet
with the addition of meat to increase diversity performed better on memory tasks
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compared to animals that received the pellets alone (Li et al., 2009). Alternatively, a high
sugar diet resulted in a significant decline on Morris Water Maze performance one-hour
post training in Long Evans rats (Magnusson et al., 2015). This effect was exacerbated
after receiving the high sugar diet for five weeks (Jurdak et al., 2008) as opposed to two
weeks (Magnusson et al., 2015), suggesting that a long-term diet that consists of higher
amounts of sugar compared to controls may increase the observed deficits in memory.
In addition to observed decreases in neural activity and memory due to alterations
in the gut microbiome, a relationship between changes in gut composition and
neurodegenerative diseases, disorders of both memory and neurogenesis, have been
observed. As previously mentioned, chronic, low levels of inflammation have been
hypothesized to be caused by an altered gut microbiome (Guigoz et al., 2008). The
resulting chain reaction that ultimately results in neurodegeneration is thought to be the
cause of β-Amyloid build up in the brain, the hallmark feature of Alzheimer’s Disease
(Quigley, 2017). In human studies, the composition of the gut microbiome has included
decreases in anti-inflammatory commensal bacteria and an increase in proinflammatory
bacteria (Quigley, 2017), which have been observed to more strongly activate the
inflammatory response than do other gram-positive bacterial strains (Guigoz et al., 2008),
and include: Enterobacteria (Guigoz et al., 2008), Proteobacteria (Biagi et al., 2010), and
Enterococcaceae (Quigley, 2017). Additionally, early life stress created by maternal
separation in rodents has been associated with increased levels of corticosterone and proinflammatory cytokines, which can have implications resulting in decreased memory
performance, as the hippocampus has large numbers of glucocorticoid receptors, and
depression later in life (O’Mahony et al., 2009). Taken together, factors that negatively
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impact the gut microbiome can result in increased inflammation that can ultimately lead
to memory disadvantage and depression.
Microbiome Diversity on Depression and Anxiety
While the link between gut microbiome diversity and memory has been well
tested in animals, similar observations have been made in human studies of gut flora
diversity and stress. Bacterial alterations have also been observed in disorders caused by
excess inflammation, which suggests a link between variations in the gut microbiome and
stress, anxiety, and depression (Zhou & Foster, 2015). A link between the microbiome
and stress was hypothesized to increase the prevalence of depression, particularly in
patients with increased proinflammatory cytokines (for review, see Collins and Bercik,
2009). More recently, diagnosed depression has been linked to specific gut bacteria,
including reduced Bacteroidetes, increased proinflammatory Alistipes (Naseribafrouei et
al., 2014), and increased pathobiontic bacteria, Proteobacteria and Actinobacteria (Jiang
et al., 2015).
Anxiety-like behavior is largely affected by gut microbiome diversity. Studies
using mice specifically colonized with commensal bacteria exhibited reduced anxietylike behaviors (for review see Foster & McVey Neufeld, 2013; Zhou & Foster, 2015).
Alternatively, colonizing the gut microbiome with pathogenic bacteria resulted in an
increase in observed anxiety-like behavior in the elevated plus maze and the holeboard
test (for review see Foster & McVey Neufeld, 2013). Animals that experienced gut
microbiome insult from both parasitic infection and inflammation exhibited increased
anxiety-like behavior; however, probiotic administration reversed this effect (for review
see Foster & McVey Neufeld, 2013).
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Antibiotics and Probiotics on Neurogenesis, Memory, and Depression
The hippocampus is largely involved with memory recall ability. Alterations in
neurogenesis here can provide stronger evidence for observed changes in memory
performance. Exposure to antibiotics has been shown to not only reduce levels of
neurogenesis in the hippocampus in young rodents (2 to 4 months), but also mature
neurons (labeled with NeuN), transient proliferating mitotic neuronal progenitor cells
(labeled with doublecortin), and proliferating neurons (labeled with BrdU) were all
actively reduced compared to control groups (Möhle et al., 2016). Therefore, antibiotic
administration can have a negative impact on hippocampal neurogenesis. In addition to
the adverse effects on neurogenesis, a reduction in gut flora diversity due to antibiotic
administration resulted in a detriment to neural activity; specifically, a decreased firing
rate, number of bursts, and percentage of spikes per burst in the dorsal CA3 hippocampal
region in mice (Guida et al., 2018) have all been observed. Ampicillin, a beta-lactam
antibiotic (Schliamser, Cars, & Norrby, 1991), resulted in a decrease in BrdU-positive
cells in both the olfactory bulb and the subgranular zone of the hippocampus (Sawada et
al., 2018), areas recognized to largely undergo neurogenesis. Interestingly, this effect
was observed to be more potent in animals treated with ampicillin compared to other nonpenicillin derived antibiotics, such as vancomycin (Sawada et al., 2018). The observed
decrease in the rate of neurogenesis and memory performance due to antibiotic usage can
have adverse effects on the health and behavior of the organism if left untreated.
Memory deficits in response to antibiotic administration have been observed in
both humans and animals. Specifically, beta-lactam antibiotics, such as ampicillin, have
been observed to have adverse effects such as memory difficulties, confusion,
disorientation, and delirium in humans (Chow, Hui, & Szeto, 2005). In animals, repeated
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administration of antibiotics (ampicillin, cefoperazone, and cefoperazone + ampicillin)
resulted in reduced memory performance on the novel object recognition task compared
to control groups (Ceylani, Jakubowska-Dogru, Gurbanov, Teker, & Gozen, 2018; Guida
et al., 2018; Möhle et al., 2016). In addition to observed deficits on the novel object
recognition task in animals, working memory tested via the Y maze, and social
recognition memory were tested in animals treated with ampicillin, streptomycin, and
clindamycin (Guida et al., 2018). Social recognition memory and novel object
recognition were both found to be significantly impaired in the treatment group compared
to controls (Guida et al., 2018); however, the researchers found no change in working
memory in mice treated with antibiotics. It is likely due to the fact that working memory
is not largely a hippocampally dependent task, therefore deficits to the hippocampus may
not result in working memory impairment. In addition to behavioral observation, the
effects of antibiotics on memory can also be observed at the neural level.
Although antibiotics have been observed to have negative effects on the gut
microbiome, the brain, and behavior, strong evidence suggests that probiotic treatment
can restore rates of neurogenesis back to baseline levels after experiencing prior deficits.
For example, probiotic treatment fully restored rates of neurogenesis immediately
following antibiotic treatment; however, probiotic treatment was unable to increase rates
of neurogenesis above its baseline levels (Möhle et al., 2016). More colloquially,
probiotic administration can attenuate the impact of antibiotics and restore that organism
to its previous level of functioning, but cannot improve upon baseline levels of
functioning. Interestingly, mice were protected from brain injury if they received
probiotics (Clostridium butyricum) prior to sustaining the injury (Sun et al., 2016).
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Additionally, pretreated, brain-injured animals had lower numbers of apoptotic cells
(measured via Bax and Bcl-2) compared to brain-injured animals that did not receive
pretreatment with probiotics (Sun et al., 2016). Probiotic pretreatment also had beneficial
effects on neurogenesis by significantly increasing BDNF and decreasing microglial
activation, part of the immune response (Ait-Belgnaoui et al., 2014). These findings
provide evidence that probiotics may not be able to improve beyond baseline ability, but
instead have the ability to restore neurogenesis effects following antibiotic insult or
buffer the effects of adverse experiences before they happen.
Probiotic administration has been observed to be beneficial in restoring memory
ability in organisms with previously observed deficits in memory performance. Probiotic
treatment was observed to rescue performance on the novel object recognition task to
baseline levels in animals previously treated with antibiotics (Möhle et al., 2016), as well
as improve stress-induced memory dysfunction following Citrobacter rodentium
infection (Gareau et al., 2011). Illnesses that slow down metabolism (e.g., diabetes) lead
to an increase in inflammation, which results in decreased neurogenesis and memory
impairment (Shalev & Arbuckle, 2017). Davari and colleagues (2013) observed a
restoration in spatial memory performance, via the Morris Water Maze, in diabetic rats
that received Bifidobacteria and Lactobacillus probiotic treatment compared to diabetic
controls. Moreover, control rats that received probiotics performed better on the Morris
Water Maze task than did the control group that did not receive probiotics (Davari et al.,
2013). This suggests that the usage of probiotics may restore memory performance in
disadvantaged rats, and bolster memory performance in experimentally naïve animals.
Although evidence supports the benefits of probiotic administration on memory
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performance, assessment of memory impairment at the neural level is required to
strengthen this argument.
The reestablishment of gut bacteria via probiotics has also shown to be beneficial
in the treatment and prevention of depressive- and anxiety-like behaviors, often defined
as reduced movement and decreased exploration in an open field (O’Mahony et al., 2009;
for review, see Sarkar et al., 2016). Specifically, the administration of the probiotic
Bifidobacterium infantis in Sprague-Dawley rats aided performance on the forced swim
task, decreased inflammation, and decreased corticotropin-releasing factor to levels
comparable to rats that received an antidepressant medication (Sarkar et al., 2016).
Similarly, fewer depressive-like (measured via the forced swim task) and anxious
behaviors (measured via the elevated plus maze) were observed in mice treated with
Lactobacilli (Sarkar et al., 2016). Matthews & Jenks (2013) found that mice that
received a probiotic that contained Mycobacterium vaccae exhibited reduced anxiety-like
behavior in a maze-learning task and exhibited improved performance on the task such
that they completed the maze faster with fewer errors compared to mice that did not.
Together these findings provide mounting evidence that animals treated with probiotics
display reduced anxiety- and depressive-like behavior in conjunction with improved
performance on these tasks. Similar effects have been observed in humans diagnosed
with depression; specifically, the reestablishment of the gut microbiome via probiotic
administration resulted in more participants rating themselves as feeling happy rather
than depressed compared to individuals in the study that received a placebo (Benton,
Williams, & Brown, 2007). Furthermore, healthy individuals administered probiotics
rated themselves as having improved mood significantly more than healthy individuals
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who received a placebo (Messaoudi et al., 2011). Importantly, the beneficial effects of
probiotic treatment have been observed in both animal and human studies.
Increased gut flora diversity has been shown to protect against the negative effects
of stress. After establishing the gut microbiome using Bifidobacterium strains in GF
mice, their stress responses were significantly reduced compared to GF animals with
unestablished gut microbiomes (Sudo et al., 2004). A similar effect was observed when
pre-existing Lactobacilli populations prevented the emergence of pathobiontic bacteria
(e.g., Proteobacteria) that target the gut (Bailey & Coe, 1999). Lactobacilli has been
shown to be reduced by situations of chronic stress, including early life maternal
separation (Gareau, Jury, MacQueen, Sherman, & Perdue, 2007), leading to an increased
likelihood of pathogenic bacterial infection (Bailey & Coe, 1999). However,
administering probiotics were found to ameliorate stress-induced changes in the gut
(Eutamene & Bueno, 2007) as well as halt the reduction in established Lactobacilli
(Gareau, Jury, MacQueen, Sherman, & Perdue, 2007). These observed behavioral effects
of both enhancing and diminishing Lactobacilli presence highlight the importance of this
bacterial genus. The effects of probiotics have also been observed at the hormonal level;
animals that received probiotics exhibited a reduction in corticosterone release in
response to stress compared to controls, which suggests that the administration of the
probiotics reduces the activity of the HPA-axis (for review see Sarkar et al., 2016). In
humans, healthy individuals administered a probiotic had reduced cortisol in their urine
compared to healthy individuals who received a placebo (Messaoudi et al., 2011). This
provides stronger evidence for the relationship between the reduction of stress and
improved memory performance in both humans and animal models.
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At the neural level, probiotics have been observed to aid in the prevention of
neurodegeneration in addition to improving memory and neurogenesis, as previously
discussed. For example, probiotics have been observed to influence the impact of
neurodegenerative diseases by reducing HPA axis activation, resulting in a reduction of
cytokines, thereby reducing inflammation (for review see Westfall et al., 2017).
Additionally, treatment with a probiotic that contained Bacteroides fragilis was found to
have neuroprotective effects of demyelination, and reduced the effects of experimental
autoimmune encephalomyelitis, an animal model of neurodegenerative disorders (Kwon
et al., 2013; Ochoa-Reparaz et al., 2010). These neuroprotective effects are believed to
occur due to the reduction of pathogenic cytokines and increase in beneficial cytokines
(Kwon et al., 2013). To reiterate, antibiotics, particularly beta-lactam antibiotics, have
adverse effects on memory performance, neurogenesis and depressive-like behavior,
while probiotics can ameliorate these effects, restoring the organism to their previous
level of ability.
Microbiome Diversity and Aging
As people age, they experience a decrease in gastrointestinal tract (GIT)
functioning, which leads to alterations in the composition of the gut microbiome (Kato et
al., 2017). The decrease in GIT function may lead to a decreased host resistance,
allowing some gut bacteria to initiate an immune response, infect, and attack other organs
(Mitsuoka, 2014). Alterations to the gut microbiome composition are highlighted in
studies analyzing the microbiome of older adults and centenarians (i.e., individuals aged
100+ years). When comparing the gut microbiome compositions of young adults, elderly
individuals (i.e., aged 70+ years), and centenarians, the gut composition (Bacteroidetes,
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Bifidobacteria, Betaproteobacteria, and Deltaproteobacteria) of individuals in the
centenarian group was significantly different from younger adults and elderly
(Actinobacteria and Clostridia); (Biagi et al., 2010; Odamaki et al., 2016). More
specifically, it was observed that centenarians had a low microbiota diversity compared
to the adults in the other age groups, and an increase in proteobacteria species, anaerobic
bacteria known as pathobionts (Biagi et al., 2010). The decrease in commensal gut
bacteria species over time are believed to contribute to increased inflammation that is
observed in the elderly (Odamaki et al., 2016).
Although strong evidence exists for changes in gut bacterial diversity over the
lifespan, the most common type of commensal bacteria, Bifidobacteria, decreases in both
number and species over time (Kato et al., 2017). Specifically, B. catenulatum and B.
bifidum populations were present in all age groups except for centenarians (Kato et al.,
2017), B. breve populations were present in all individuals over the age of 50, and B.
dentium, which actually increased in individuals over the age of 60 (Kato et al., 2017).
The eradication of some species of the Bifidobacterium genus over time is likely due to
the reduced adhesion of Bifidobacteria to mucus (Guigoz et al., 2008), as bacterial-mucus
adhesion is lower in healthy elderly individuals compared to healthy adults (He et al.,
2001; Mitsuoka, 2014). This decrease in commensal Bifidobacterium over time helps
explain why many probiotics contain Bifido- species. Additionally, researchers noted
that as people age, a general increase in Enterobacteria, due to the reduced effectiveness
of gut microbiome barrier, is commonly observed (Guigoz et al., 2008; He et al., 2001;
Ouwehand, Isolauri, Krijavainen, & Salminen, 1999). This change in gut bacteria
composition is believed to be detected by the innate immune system, triggering
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inflammation, regardless of whether the bacteria is considered “healthy” or not (Guigoz
et al., 2008). In particular, nonpathogenic, gram-negative bacteria (e.g., Enterobacteria)
have been shown to more strongly activate the inflammatory response than do other,
gram-positive, bacterial strains (Guigoz et al., 2008). Although inflammation is a
common occurrence in older adults, research has shown that certain prebiotics,
probiotics, or synbiotics, the combination of pre- and probiotics, have shown antiinflammatory effects in the elderly (Guigoz et al., 2008), which further decrease HPA
axis effects on gut permeability.
In addition to changing gut microbiome composition over time, some bacterial
species are associated with increased longevity (Mitsuoka, 2014). When comparing GF
mice, conventional mice (GF mouse colonized with microbiome of non-GF mouse), and
gnotobiotic mice (contain all possible microorganisms), conventional mice had an
increased rate of pathobiontic bacteria, and therefore had a shorter lifespan compared to
GF mice (Mitsuoka, 2014). This suggests that having an increased diversity of harmful
bacteria can result in more deficits to the host compared to an organism with no
established microbiome at all. Additionally, gnotobiotic mice with B. longum had a
longer average lifespan than gnotobiotic mice without the presence of the
Bifidobacterium strain (Mitsuoka, 2014). This highlights the importance of this strain of
bacteria and organism longevity.
Diet has also been observed to effect gut microbiome diversity, and in turn,
immunosenescence (i.e., gradual deterioration of immune functioning), health, and wellbeing. Researchers found that a more diverse diet was significantly positively correlated
with gut microbiota diversity (Claesson et al., 2012). Specifically, diets low in fat and
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high in fiber had the highest microflora diversity, while diets moderate in fat and high in
fiber and diets high in fat and low in fiber had the lowest microflora diversity (Claesson
et al., 2012), suggesting the gut microbiome is regulated by the individual’s diet. One
study showed that older adults living in long-stay facilities had reduced diet diversity,
which led to a reduced gut microbiome diversity. These same adults had higher levels of
inflammation, lower scores on the geriatric depression test (GDT), and lower scores on
the mini-mental state exam (MMSE) compared to adults living in a community setting
(Claesson et al., 2012). This highlights the importance of maintaining dietary diversity
throughout the lifespan, given the natural gut microbiome changes that occur. These
changes, compounded by a lack of dietary diversity, can have major effects on the brain
and behavior.
Antibiotics and Probiotics on Aging
Beta-lactam (β) antibiotics are a class of antibiotics that consist of a beta-lactam
ring structure (Abraham, 1981). This class of antibiotics includes the penicillins
(Abraham, 1981) and any of its derivatives, including: cefazolin, imipenem, and
ampicillin (Schliamser, Cars, & Norrby, 1991). In humans, these antibiotics have
adverse effects such as nervous system hyperactivity, seizures, comas (Lerner et al.,
1967), encephalopathies (Grill & Maganti, 2011), confusion, disorientation, and
excessive drowsiness (Chow, Hui, & Szeto, 2005). Beta-lactam antibiotics have also
been shown to have higher neurotoxic side effects compared to other compounds,
particularly when applied directly to the brain (Schliamser et al., 1991). The risk of
neurotoxic reactivity is increased among those with decreased renal function (RodriguezJulbe et al., 2004), blood-brain barrier damage, and old age (Chow et al., 2005;
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Schliamser et al., 1991). This neurotoxic quality of beta-lactam antibiotics, combined
with their frequent use to treat bacterial infection, may be a contributing factor to the
increased cognitive deficits observed in old age. In addition to the observed effects of βlactam antibiotics in central-nervous-system-compromised and elderly individuals, βlactam antibiotics have been observed to affect young children (Grill & Maganti, 2011).
More specifically, ampicillin has induced neurotoxic effects in newborn children likely
due to the increased permeability of the blood-brain barrier (Grill & Maganti, 2011).
Adverse effects of antibiotic use have also been observed in animals and studies
suggest that early administration can cause long-term effects on longevity, gut-bacteria
diversity, and the brain and behavior. Repeated administration of antibiotics (ampicillin,
cefoperazone, and cefoperazone + ampicillin) in juvenile mice resulted in both acute and
long-term effects (Ceylani, Jakubowska-Dogru, Gurbanov, Teker, & Gozen, 2018).
Acute effects included a significant decrease in locomotor activity and an increased
immobility time in the forced swim task (Ceylani et al., 2018). Long-term effects of
juvenile antibiotic administration resulted in reduced memory performance on the novel
object recognition task, a decreased diversity in established gut bacteria, and an increase
in new gut bacterial strains compared to control groups at two months of age (Ceylani et
al., 2018). Long-term β-lactam antibiotic administration has been observed to increase
the prevalence of obesity and reduce caloric excretion in mice compared to controls (Cho
et al., 2012). Antibiotic administration to dams during late pregnancy has also been
observed to have effects on pups’ gut microbiota diversity at birth lasting to six weeks of
age (Leclercq et al., 2017). When administered at the perinatal period, β-lactam
antibiotics led to an observed increase in aggressive behavior, decrease in social novelty,
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decrease in sociability, increased cytokine expression, and a decreased bacterial diversity
(Bacteroidetes, Firmicutes) in the pups compared to control groups (Leclercq et al.,
2017). Additionally, a decrease in bacterial diversity of the dams was observed
(Cyanobacteria, Actinobacteria, Proteobacteria; Leclercq et al., 2017). In mice treated
with antibiotics, Proteobacteria, pathobionts, were found to be significantly more
abundant compared to controls (Leclercq et al., 2017). Proteobacteria are known to be
positively correlated with pro-inflammatory cytokines in humans, which provides further
evidence of increased inflammation that is a characteristic of old age (Biagi et al., 2010).
More specifically, antibiotics increase proteobacteria, which exacerbates chronic
inflammation that already occurs in old age. Although these studies provide strong
evidence that antibiotic usage can have long term effects on the brain and behavior, even
after the cessation of administration, the long-term effects of repeated antibiotic
administration from post-weaning to old age has not yet been assessed.
There have been mixed reviews regarding the effects of antibiotics on health and
behavior in older adults. In a review conducted by Moore and O’Keeffe (1999),
antibiotics were found to be linked to delirium and psychiatric illness in older adults due
to the body’s decreased ability to maintain homeostasis. This antibiotic-illness link has
been hypothesized to occur due to antibiotics’ ability to inhibit GABA neurotransmission,
as well as individual risk factors such as advanced age, decrease in blood-brain barrier
effectiveness, and systemic administration (Moore & O’Keeffe, 1999). Interestingly,
research suggests that diet is a more important indicator of microbiome diversity than
past usage of antibiotics (Claesson et al., 2012). When comparing older adults prescribed
long-term antibiotics to older adults without antibiotics, there were no observed
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confounding effects of antibiotic usage on microbiota and health relationships or diet and
health relationships (Claesson et al., 2012). However, antibiotics have been shown to
alter gut flora diversity and also shift the pre-existing diversity in both older adults living
in long-term care and in the community (for review see Buford, 2017). When comparing
younger adults (20 to 59) to older adults (60 to 85), individuals in the older age group had
higher blood-antibiotic levels across all antibiotics studied (Liu et al., 2017). This may
occur as a result of an increased gut permeability due to both age and antibiotics
(O’Toole & Claesson, 2010), and subsequently lead to the inability to metabolize and
excrete bacterial byproducts (Woodmansey, McMurdo, Macfarlane, & Macfarlane,
2004). Further research is necessary to compare the effects of antibiotics on the gut
microbiome, brain, and behavior across age groups.
Although there is evidence that antibiotics can have adverse effects on the gut
microbiome and health across the lifespan, probiotic administration has been shown to
help ameliorate these negative effects. Probiotics have been observed to reverse the
effects of a reduced gut microbiome barrier that may occur due to antibiotic
administration (Hsiao et al., 2013) or age (for review see Guigoz, Dore, & Schiffrin,
2008). Probiotic administration following antibiotic administration during the perinatal
period prevented decreases in social novelty, sociability, Enterobacteria (a pathobiontic
species), and anxiety-like behavior (Leclercq et al., 2017), and has been observed to
increase the average lifespan and locomotor activity while reducing biological markers of
aging (lipofuscin) of C. elegans treated with Bifidobacteria (Komura et al., 2013).
Lastly, probiotics have been observed to have protective factors against the development
of neurodegenerative diseases by reducing inflammation in the gut microbiome (Westfall
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et al., 2017) that is a hallmark of aging (Guigoz et al., 2008). Research supports the
benefits of probiotic administration across the lifespan, especially in conjunction with
antibiotic treatment; however, further research is necessary to compare these benefits
across age groups.
Overview of the Current Study
While the effects of antibiotics and probiotics on the rate of neurogenesis,
memory task performance, and depression are well established, it is unknown whether or
how these affect age groups differently. The current study seeks to investigate the effects
of both antibiotics and probiotics on memory, hippocampal cell count, and depressive
behavior in both young and old rats. If antibiotic usage substantially reduces the gut
microbiome, it is expected that animals receiving antibiotics without probiotic recovery
will perform worse on a memory task, have a reduced number of cells in the granule
layer within the dentate gyrus of the hippocampus, and exhibit more depressive-like
behavior compared to both naïve animals and animals that receive probiotics. Because
probiotics have been shown to restore the gut flora diversity, rats that are treated with
probiotics are expected to perform similarly to naïve animals on the behavioral tasks, and
show similar hippocampal cell count. Although some age-related differences in
performance on the object location task and forced swim task are expected, it is expected
that antibiotic administration to older animals will exacerbate these age-related deficits
more so than in the young animals. In addition, it is expected that older rats receiving
antibiotic treatment will have a lower hippocampal cell density compared to younger rats
in the same treatment group. Finally, it is hypothesized that older animals will be less
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responsive to probiotic recovery after previously receiving antibiotic treatment, due to the
decreased bacterial adhesion in older organisms.
Previous research has demonstrated that the use of antibiotics has adverse effects
on hippocampal neurogenesis, memory performance, and measures of depression, while
probiotics can rescue the adverse antibiotic effects. However, these effects have not yet
been compared across age groups. The current study will attempt to replicate prior
research regarding the gut-brain axis, while providing a novel, and important contribution
by examining multiple age groups. Originally, the current study attempted to replicate
previous findings of reduced neurogenesis in the subgranular zone within the dentate
gyrus of the hippocampus by performing a count of nissl stained cells across all age and
treatment groups. However, the fixation method used failed to effectively penetrate the
region of interest and therefore nissl bodies could not be stained. These methods are
examined further in the discussion. However, research on behavioral outcomes are
important due to the increased use of prescription antibiotics and antibiotic usage in food
products. In fact, the abundance of antibiotic exposure has led to an observed increase in
antibiotic resistance (Karp & Engberg, 2004). The current study aims to provide a more
complete picture of the connection between the brain and the gut by contributing to the
growing body of literature assessing the influence of the gut microbiome on cognition.
This is a step towards better understanding the role of the gut microbiome on the
development of psychiatric illness (e.g., depression), and age-related illnesses (e.g.,
Parkinson’s Disease and other dementias), illnesses recently speculated to have origins in
the gut.
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Method
Animals
Twenty-five young (2 months at acquisition) and twenty-five old (12-13 months
at acquisition) male Long-Evans rats weighing between 300-800 grams were utilized in
the study over a four-week period divided into two consecutive treatment periods that
lasted three weeks and then one week respectively (see Figure 1). Young animals were
obtained from Charles River, and old animals were obtained from Envigo. All animals
were treated according to guidelines set forth by the IACUC and kept on a 12-hr reverse
light/dark cycle (lights off at 0800) with free access to food and water.
Procedure
Prior to behavior testing, animals were randomly assigned to one of five possible
treatment groups. Animals that did not receive either antibiotic or probiotic treatment
(Naïve) served as one control group, while animals that did not receive antibiotic
treatment but received probiotic treatment (No Treatment + Probiotics) served as the
other. Additionally, animals assigned to first receive antibiotic treatment were assigned
to later receive no treatment (Antibiotics + No Treatment), probiotic treatment
(Antibiotics + Probiotics), or were sacrificed immediately following antibiotic treatment
(Antibiotics Only). All animals underwent pre-test behavioral measures to establish
baseline memory performance on the object location task and baseline depressive
behavior as measured by the forced swim task. Behavior testing occurred over a period
of three days. On day one, animals completed the “study” phase for the object location
task. The following day, animals were tested on the object location task, allowed to rest
for 5 minutes, and then endured forced swim habituation before they were returned to
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their home cage. On the last day, animals underwent the forced swim test phase. All
behavior test days began at 0900 and ended by 1200. Following baseline behavioral
measures (B), animals assigned to receive antibiotic treatment began antibiotic (1.5 g/L
ampicillin) administration via drinking water for a period of 3 weeks. Animals that did
not receive antibiotics received regular tap water during this 3-week period. Immediately
following three weeks, all animals underwent the same battery of behavioral tests (T1).
Animals in the Antibiotics Only condition were sacrificed to undergo tissue staining
immediately following behavior testing, in order to determine the immediate effect of
antibiotic treatment without a recovery period. During the following week, animals
randomly assigned to the probiotic treatment groups began probiotics (1 x 109 CFU/mL)
administered via drinking water. Animals that did not receive probiotics received regular
tap water during the 1-week period. Immediately following the 1-week treatment, all
animals endured a final battery of behavioral testing before being sacrificed for tissue
staining (T2). All animals’ water intake was tracked for the duration of the study in order
to determine the actual antibiotic and probiotic concentration consumed by each animal.
See Figure 1. All procedures outlined in this protocol were approved by the IACUC.
Treatment
Ampicillin Sodium Salt (crystalline powder) antibiotics were purchased from
Fischer Scientific (Fischer Scientific International, Inc., Hampton, NH) and stored at 4
°C. Antibiotic were dissolved in DI water to a concentration of 1.5 g/L and stored at 4 °C
for up to one week at a time. Antibiotics were administered ad libitum via the drinking
water rather than via oral gavage to minimize any effects of stress on the animals, and
served as the only access to drinking water. To ensure animals still consumed a healthy
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amount of water, daily water intake (g) was recorded for a period of three weeks. A
dosage of 1.5 g/L was chosen as a theoretical equivalent of 500mg dosage twice daily in
humans and were based on dosages from previous research (Möhle et al., 2016).
Primal Gut Powder probiotic blend (20+ billion Colony Forming Units (CFUs))
was purchased from Corganic and stored at 4 °C. Primal Gut Powder contains 12+
billion Lactobacillus species, including: L. rhamnosus, L. casei, L. acidophilus, L.
plantarum, L. paracasei, L. brevis, L. salivarius, and L. gasseri. Additionally, Primal
Gut Powder contains 8+ billion CFUs of Bifidobacterium species, including: B. infantis,
B. longum, B. bifidum, B. breve, and B. lactis. Probiotics were dissolved in DI water to a
concentration of 1 x 109 CFU/mL and stored at 4 °C for up to one week at a time. A
dosage of 1 x 109 CFU/mL Lactobacilli and Bifidobacteria were chosen based on
previous research (Savignac et al., 2015). Probiotic strains were chosen based on their
frequency of occurrence in the gut microbiome and because ampicillin targets these
strains. Similar to antibiotics, probiotics were administered ad libitum via the drinking
water, and daily water intake (g) was recorded for a one-week period.
Object Location Task
The object location memory task is a task that specifically assesses spatial
memory and discrimination in rodents. Training procedures were adapted from VogelCiernia & Wood (2008), and adjusted for use with rats. Before baseline testing, animals
were acclimated to an empty testing environment twice for five minutes each (83.8 cm x
51.5 cm x 34.3 cm). During testing, the open field was divided into four equal
quadrants. Four objects of similar size and material but differing in shape were Velcroed
to the floor of the open field chamber, one in each quadrant. Each individual animal was
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allowed to explore the area and the objects for five minutes to serve as the learning phase.
Twenty-four hours later, in the recall phase, each animal was returned to the open-field
with the same four objects from the day before, but with two objects having swapped
quadrants. The amount of time the animal spent with each object was video recorded.
Object discrimination was assessed by two blinded scorers, and based on the amount of
time each animal spent with an object in a novel quadrant compared to an object in a
familiar quadrant. The field and objects were sanitized between each test in order to
avoid possible influences on other animals.
Forced Swim Task
The forced swim test examines depressive-like behavior in rodents. Training
procedures were adapted from Yankelevitch-Yahav, Franko, Huly, and Doron (2015).
Plastic containers (12.00 in x 16.85 in x 14.24 in), used for juvenile animals, were filled
with tap water and adjusted for the animal’s size. Glass cylinders (57 cm x 20 cm), used
for older animals due to their larger size, were filled with tap water, adjusted for the
animal’s size and so that its hind legs could not touch the bottom of the container. Water
was maintained at a temperature range of 22-24 °C. Each animal underwent a 15-minute
pretest that served as the habituation phase. Twenty-four hours later, each animal was
placed in the container for a maximum duration of five minutes, and the amount of time
spent immobile rather than actively trying to escape was recorded as a measure of
depression. After the five-minute time limit was reached, the rat was removed from the
container, dried off with a towel, placed in a drying cage with a heating pad under the
cage, and monitored until fully dry prior to being returned to its home cage. Water was
changed between each of the animals to avoid possible influence on other animals.
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Histology
Brain tissue was extracted, immersion fixed in 4% paraformaldehyde solution,
and sliced into 100 μm sections using a cryostat then mounted on slides to dry overnight.
The following day, slides were rehydrated through 100%, 95%, and 70% alcohol distilled
water in order to reduce background fat staining. A 0.1% cresyl violet solution was
warmed between 37-50 degrees to improve penetration and enhance staining. Sections
were submerged in cresyl violet solution for 2-10 minutes and then rinsed quickly with
distilled water. Slides were then placed in 95% ethyl alcohol for 30 sec, dehydrated in
100% alcohol twice for 5 min each and cleared in xylene twice for 5 min each before
being fixed with DPX permanent mounting medium. At this point, it was determined that
immersion fixation in 4% paraformaldehyde was not sufficient to fix the medial dentate
gyrus structures and is further highlighted in the discussion.
Statistical Analyses
Mixed ANOVAs explored the effects of age, treatment, and individual changes
from baseline testing on variation in each behavioral variable (spatial memory measured
by object location and depression measured by forced swim). Therefore, a 2 (age group:
juvenile, old) x 5 (treatment: Antibiotics + No Treatment, No Treatment + Probiotics,
Antibiotics + Probiotics, Naïve, and Antibiotics Only) x 3 (Testing Session: Baseline,
Time 1 (following 3 weeks), Time 2 (following 1 week)) mixed ANOVA was conducted
in SPSS for each behavioral dependent variable. Age and Treatment were treated as
between-subject variables while Testing Session was treated as a within-subject variable.
For all ANOVA analyses, main effects and interactions were examined. Due to a priori
hypotheses, t-tests examined differences between antibiotic and probiotic treatment
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groups and compared to controls, regardless of main effect significance to determine
differences in task performance and water consumption.
Finally, simple linear regressions were used to determine if the amount of
antibiotics consumed had an impact on object location performance or forced swim test
performance following antibiotic treatment (T1). Additionally, simple linear regressions
examined whether the amount of probiotics consumed by each animal predicted
performance on the object location task or forced swim test following probiotic treatment
(T2). Multiple regression analyses were conducted to determine whether adding the
categorical treatment group variable would explain significantly more variance in both
object location performance and forced swim performance above and beyond the
continuous antibiotic and probiotic consumption variables.
Results
Upon completion of the study, only 48 of the 50 animals were used in the final
object location analysis. Only 47 were used in the final forced swim analysis. Animals
were excluded from analyses due to health complications. Data were analyzed in
accordance with previously published studies (Möhle et al., 2016) that utilized the forced
swim task and the novel object location task. For analyses of the object location task,
assumptions were not violated, including: normality, homogeneity of variance, and
sphericity (𝜒 2 (2) = 1.10, p = .578). When evaluating homoscedasticity of these data
beyond homogeneity of variance testing, Hartley’s Fmax was conducted, and ratios were
found to be homogenous for both the object location task and the forced swim test.
Additionally, QQ plots suggested that the data were homoscedastic. For the forced swim
task, assumptions were not violated (sphericity: (𝜒 2(2) = 3.19, p = .203) with the
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exception of normality due to the presence of one outlier; however, all cases were left in
the data set to provide a more accurate representation of the data. Descriptive statistics
for each behavioral task are presented in Table 1 and 2.
Object Location Task
It was originally predicted that animals that received antibiotics would spend less
time with objects in novel locations compared to animals that did not receive antibiotics.
Object location performance did not differ between the Treatment Groups when
collapsing across Testing Session and Age, F(4, 38) = 1.58, p = .198, ηp2 = .143.
Observed power was .44. However, this was a medium effect size, where 14.3% of the
variance in object location performance could be explained by treatment group. Animals
receiving antibiotics and probiotics (M = 35.73) performed better than those who only
received antibiotics (Antibiotics + No Treatment group, M = 16.70; Antibiotics Only
group, M = 22.78), only received probiotics (M = 11.57), and animals that did not receive
treatment at all (M = 21.50).
Older animals were predicted to spend less time with the novel object locations
compared to juveniles, especially if the animals additionally received antibiotics.
Collapsing across treatment groups and testing session, performance on the object
location task did not differ between the old and young animals, F(1, 32) = 0.83, p = .368,
ηp2 = 0.03, which is a small effect. Observed power was 0.03. When collapsing across
treatment group and age, a significant effect of testing session was found F(2, 64) =
5.145, p = .008, ηp2 = 0.14, such that time spent with novel locations at Baseline (M =
27.24, SD = 30.85) was significantly greater than the time spent with the novel object
locations at Time 2 (M = 4.13, SD = 37.91), p = .012, 95% CI [4.34, 43.17]. The partial
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eta squared effect size was medium, where 14% of the variance in object location
performance could be explained by testing session. The observed power was .81.
Bonferroni corrections were conducted for all post-hoc t-tests to correct for Type I error.
Differences across testing sessions did not vary between Time 1 (M = 15.78, SD = 28.51)
and Baseline, t(47) = 2.11, p = .211, 95% CI [-4.38, 29.41] or between Time 1 and Time
2, t(39) = 1.39, p = .479, 95% CI [-8.48, 30.95]. No significant interactions were found
for Testing Session and Treatment Group (p = .417), Testing Session and Age (p = .371),
or Testing Session, Treatment Group, and Age (p = .203), meaning that object location
performance did not depend upon the age of the animal or treatment group membership
(see Table 3).
In order to determine whether animals spent more time exploring any of the
objects (i.e., novel or familiar) at any given time point, a repeated measures ANOVA was
conducted. Mauchly’s test of sphericity indicated that sphericity had been violated for
total object location exploration time, so a Greenhouse-Geisser adjustment was used to
adjust degrees of freedom (χ2 = 38.42, p < .001). Performance did not vary between the
behavior tests, such that animals did not differ in their exploration of any object, novel or
familiar (F(1.22, 47.67) = 0.03, p = .170, ηp2 = 0.05), which is a small effect.
Forced Swim Test
For the forced swim test, it was predicted that animals that received antibiotics
would spend more time inactive compared to animals that did not receive antibiotic
treatment. Collapsing across testing session and age group, forced swim performance did
not differ between the treatment groups, F(3, 32) = 0.50, p = .684, ηp2 = 0.05, with an
observed power of .14 (See Table 4). The partial eta squared effect size was very small,

MICROBIOME, MEMORY, DEPRESSION, AND AGE

31

such that 5% of the variance in forced swim task performance could be explained by
treatment group. Moreover, older animals were predicted to spend more time inactive,
particularly if they had previously received antibiotics. However, juveniles (M = 107.18,
SD = 47.24) spent more time inactive compared to adults (M = 47.30, SD = 50.79), F(1,
32) = 16.51, p < .001, ηp2 = 0.34, regardless of Treatment Group or Testing Session. This
effect size was large, where age accounted for 34% of the variance in forced swim task
performance. The observed power was 0.98. Differences across testing session did not
vary when collapsing across age and treatment group, F(2, 64) = 1.77, p = .178, ηp2 =
0.05, with an observed power of .36. Lastly, there were no significant interactions for
Testing Session and Treatment Group (p = .864), Testing Session and Age (p = .075), or
Testing Session, Treatment Group, and Age (p = .206), meaning that performance on the
forced swim task did not depend upon the animals age or the treatment group to which
they were assigned. Bonferroni corrections were used to control for Type I error.
Treatment Dosage
In order to determine whether the amount of water consumed differed between
treatment groups and age during the three-week period of antibiotic treatment, a 2 (age) x
5 (treatment group) ANOVA was conducted. Importantly, even though treatment was
administered via drinking water, the amount of water consumed did not differ between
the treatment groups, F(4, 39) = 1.24, p = .311, when collapsing across age groups.
Regardless of treatment group, juveniles (M = 53.53, SD = 7.18) consumed significantly
more water during the three-week interval following baseline testing than the adult
animals (M = 34.50, SD = 7.18), 95% CI [15.44, 22.95] (F(1, 39) = 106.86, p < .001, ηp2
= 0.73). The observed power was greater than .999 (See Table 5). This was a large
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effect, such that age accounted for 73% of the variability in water consumption. When
analyzing the amount of water consumed between treatment groups during the threeweek period between Baseline testing and Time 1, there was no significant interaction
between Treatment Group and Age in the amount of water consumed (F(4, 39) = 0.72, p
= .581).
To determine if there were differences between both age and treatment groups in
the amount of water that contained probiotic treatment consumed compared to water that
did not contain probiotic treatment, a 2 (age) x 4 (group; Antibiotics Only animals were
sacrificed following Time 1 behavior testing) ANOVA was conducted. Unlike with
antibiotic consumption, water consumption containing probiotics differed between the
treatment groups, across all age groups, F(3, 32) = 15.89, p < .001, ηp2 = 0.03.
Specifically, animals drank more probiotic water following antibiotic treatment (M =
48.54, SD = 16.46) than animals that did not previously receive antibiotics (M = 31.66,
SD = 11.42), p < .001, 95% CI [7.10, 26.67]. Moreover, animals in the Antibiotics + No
Treatment group (M = 54.90, SD = 13.87) consumed significantly more compared to
animals in the No Treatment + Probiotics Groups, p < .001, 95% CI [13.45, 33.02].
Lastly, animals in the Naïve Group (M = 45. 39, SD = 11.84) consumed significantly
more water compared to animals in the No Treatment + Probiotics Group, p = .002, 95%
CI [3.94, 23.51]. There was no significant interaction found for Treatment Group (i.e.,
not including Antibiotics Only group as they were sacrificed prior to Time 2) and Age in
the amount of water consumed between Time 1 and Time 2, F(3, 32) = 2.173, p = .110.
Moreover, animals in the Antibiotics + No Treatment group (M = 54.90, SD = 13.87)
consumed significantly more compared to animals in the No Treatment + Probiotics
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Groups, p < .001, 95% CI [13.45, 33.02]. Lastly, animals in the Naïve Group (M = 45.
39, SD = 11.84) consumed significantly more water compared to animals in the No
Treatment + Probiotics Group, p = .002, 95% CI [3.94, 23.51]. A significant main effect
(though small effect size) for age was also found, F(1, 32) = 70.62, p < .001, η2 = .05,
where animals in the Juvenile age group (M = 55.46, SD = 14.55) consumed significantly
more water than animals in the Adult age group (M = 34.78, SD = 7.92), 95% CI [15.66,
25.67]. See Table 6.
Simple linear regression was used to determine the effects of antibiotic
consumption on behavioral task performance. The average amount of antibiotics
consumed per kilogram body weight significantly predicted forced swim inactivity time
at Time 1, β = 0.73, t(1) = 2.74, p = .011, R2 = .23 (See Figure 2). The average amount of
antibiotics consumed per kilogram body weight did not predict object location
discrimination performance at Time 1, β = 0.13, t(1) = 0.85, p = .402, R2 = .03 (See
Figure 3). To provide a deeper understanding, regression was used to determine if there
were differences between age groups on antibiotic consumption predicting behavior
performance. Age did not impact the effect of antibiotic consumption per kilogram of
body weight on object location performance, such that juveniles (β = 0.34, t(1) = 0.61, p
= .555, R2 = .03) did not differ on object location performance compared to adults (β = 1.03, t(1) = -0.95, p = .359, R2 = .07; See Figure 4). Additionally, age did not impact the
effect of antibiotic consumption per kilogram of body weight on forced swim
performance; juvenile animals (β = .11, t(1) = 0.10, p = .924, R2 = .00) did not differ from
adults (β = -1.21, t(1) = -0.78, p = .452, R2 = .05) on forced swim test inactivity (See
Figure 5). Multiple regression was conducted in order to determine whether the
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categorical treatment variable explained significantly more variance in forced swim
inactivity above and beyond antibiotic consumption alone, R2change = .14, Fchange (1, 44) =
9.01, p = .004. Additionally, adding the categorical treatment variable did not explain
significantly more variance in object location discriminability above and beyond
antibiotic consumption alone, R2change = .00, Fchange (1, 45) = .01, p = .92.
Because animals in different age groups varied in body size and growth rates, a 2
x 5 ANOVA was also conducted to determine if animals differed in treatment
consumption (mL) per kilogram of body weight. This revealed that juvenile animals (M
= 130.94) consumed significantly more antibiotic water per kilogram of body weight
compared to adult animals (M = 60.03; 95% CI [64.04, 77.77]), F(1, 38) = 437.10, p <
.001, ηp2 = .92. The effect size was large, such that 92% of the variance in antibiotics
consumed depended on the age of the animal. The observed power was greater than .999.
This suggests that juvenile animals received more antibiotic treatment per kilogram of
body weight compared to the adult animals.
Simple linear regression was estimated to determine whether probiotic
consumption predicted Time 2 behavior task performance. Unlike with antibiotic
consumption, the average amount of probiotics consumed did not significantly predict
Forced Swim inactivity, β = 0.33, t(1) = 0.99, p = .334, R2 = .05 (See. Figure 6).
Additionally, the average amount of water consumed that contained probiotics did not
significantly predict Object Location Task performance at Time 2, β = 0.15, t(1) = 0.90, p
= .379, R2 = .04 (See Figure 7). Lastly, regression was used to determine differences in
age groups on probiotic consumption predicting behavior performance. Age did not
differ when observing the effect of probiotic consumption on object location performance
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(See Figure 8). Juveniles (β = -0.13, t(1) = -0.71, p = .497, R2 = .06) did not differ
compared to adult animals (β = 1.73, t(1) = 1.39, p = .203, R2 = .19). Additionally, age
did not have an impact on the amount of probiotics consumed predicting forced swim
performance (See Figure 9). Juvenile animals (β = 0.15, t(1) = 0.42, p = .683, R2 = .02)
did not differ from adult animals (β = -3.73, t(1) = -1.57, p = .154, R2 = .24) on forced
swim performance following probiotic treatment. Multiple regression was conducted in
order to determine whether adding in the categorical treatment variable would explain
significantly more variance in forced swim inactivity at Time 2 above and beyond
probiotic consumption alone. Adding treatment group did not explain significantly more
variance in forced swim performance R2change = .06, Fchange (1, 17) = 1.20, p = .29. Lastly,
adding treatment variable into the model did not explain significantly more variance in
object location discriminability at Time 2 than did probiotic consumption alone, R2change =
.06, Fchange (1, 17) = 1.07, p = .316.
Finally, to determine whether animals differed in the amount of probiotic water
consumed (mL) per kilogram of body weight, a 2 x 5 ANOVA was conducted. Juvenile
animals (M = 120.93) consumed significantly more probiotic water compared to adult
animals (M = 60.21; 95% CI [49.64, 71.80]), F(1, 32) = 124.56, p < .001, ηp2 = .80. The
effect size shows that 80% of the variation in probiotic consumption could be explained
by the age of the animal. The observed power was greater than .999. This indicates that
juvenile animals received more probiotic treatment per kilogram of body weight
compared to adult animals.
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Discussion
The current study sought to accomplish two primary goals. The first goal was to
replicate previously established evidence supporting a connection between the gut
microbiome and behavior. Specifically, we examined previously established effects of
gut microbiome diversity on memory performance, the hippocampus, and depressive-like
behavior. The second goal was to compare these effects across age groups in order to
provide a deeper understanding of how changes to the gut microbiome affect depressivelike behavior, memory performance, and hippocampal cell density at various points
during the lifespan. In contrast to what was predicted, results obtained did not follow
similar trends as those observed in previously published literature. However, our results
do suggest that the amount of antibiotics consumed can impact behavior.
The amount of antibiotics consumed significantly impacted forced swim behavior.
The more antibiotics the animal consumed, the more time that animal spent inactive
during the task. Moreover, 23% percent of the variability in forced swim test
performance could be explained by the amount of antibiotics consumed. Although the
current finding did not replicate results obtained from previous studies that also
administered antibiotics via passive administration (Guida et al., 2017; Möhle et al.,
2016), this linear relationship suggests that a specific amount of antibiotic dosage is
required in order to observe the detrimental effects on behavior performance. The
amount of antibiotics consumed did not significantly predict performance on the object
location task, and only explained 3% of the variability in task performance; therefore, it is
possible that the antibiotic doses needed to observe depressive-like behavior are not the
same doses required to observe memory impairment. Instead, larger or longer antibiotic
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treatment may be necessary to observe a deficit in spatial memory performance.
Antibiotic administration via oral gavage may help ensure that all animals receive enough
of the treatment to observe an effect (Fröhlich et al., 2016). However, because of the
possible effects of stress due to repeated gavaging, passive treatment administration was
selected to prevent any adverse effects on the hippocampus and subsequent memory.
The amount of probiotic consumed did not significantly predict performance on
either the forced swim task or the object location task. At first glance, this seems to be a
negative effect in regards to using probiotics as a form of treatment. However, as
previously mentioned, probiotic treatment is not able to improve above and beyond the
organism’s previous ability (Möhle et al., 2016); instead, it can be employed to
reestablish and recover the organism’s microbiome diversity, in turn regaining previous
memory performance. Therefore, observing large differences in Time 2 performance in
animals that received probiotic treatment is unlikely. It is important to keep in mind that
a dose response relationship may also be observed in animals subjected to probiotic
treatment; however, as with antibiotics, controlled dosing is necessary to fully examine
that claim.
Antibiotic treatment did not significantly impair object location performance, and
probiotic treatment did not rescue performance. Specifically, only the groups that
received antibiotics were expected to significantly decrease from Baseline to Time 1.
Although no significant effect was observed, the variability between the groups yielded a
medium effect size, such that 14.3% of the variance in object location performance could
be explained by treatment group. Animals that received probiotics following antibiotic
administration continued to decrease in object location performance across the three
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behavioral testing sessions, which highlights the necessity to consider a dose response
relationship between both antibiotic treatment and probiotic treatment. Animals that
received antibiotics alone (i.e., Antibiotics + No Treatment or Antibiotics Only groups)
also decreased in object location performance over time, suggesting antibiotic treatment
may have resulted in impaired performance. Interestingly, the animals that received
sterile drinking water following antibiotic administration largely returned to their baseline
performance levels in the last object location testing session, which suggests that no
intervention following antibiotic administration alone may be salient enough to recover
spatial memory ability. Although no significant differences were observed between the
treatment groups via inferential statistical testing, it is important to examine effect sizes
and group trends to determine practical significance (Cohen 1992).
Object location performance decreased across the testing sessions, though this
was not originally predicted. Object location performance was expected to decrease only
following antibiotic treatment and improve if the animals then received probiotic
treatment. Instead, the ability to discriminate between the novel object locations and the
familiar object locations decreased at each testing point regardless of both age and
treatment group. Although objects were changed for each testing period, it is possible
that the task became monotonous after each repetition, so the time spent interacting with
each object decreased as the study progressed, resulting in poorer discriminability.
Additionally, it is possible that the animals that received treatment did not have their gut
microbiomes fully altered after consuming either antibiotics, probiotics, or both.
Moreover, a therapeutic dose of probiotics has yet to be established, though a few studies
recommend a daily dose of 109 to 1010 (1 x 109 CFU/mL was utilized for the current
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study) to be therapeutically beneficial (for review see Kopp-Hoolihan, 2001; Sanders et
al., 1996). Although previous research has typically utilized recognition memory tasks to
evaluate whether antibiotic insult impairs memory performance, animals in the present
study spent less time exploring objects in their novel locations compared to animals that
explored a completely novel object (Hoban et al., 2016).
Adult animals did significantly outperform juvenile animals on spatial memory
performance, which, again, was not predicted. Although possible that adult animals do
not actually differ between juvenile animals on spatial memory discriminability, the
obtained finding might result from research that suggests that Long Evans males do not
differ in hippocampal spine density when comparing rats aged 19-22 months, 24-26
months, 12 months, and 3-5 months (Luine, Wallace, & Frankfurt, 2011). Because the
ages of the animals utilized in the current study were 3-4 months and 13-14 months at
study completion, it is possible that no differences in age between the groups were
observed because age-related deficits were not yet evident. In fact, age-related deficits
are not observed until 18 months in Long-Evans rats (Bizon & Gallagher, 2003);
however, these age groups were utilized to ensure that any impairments observed
between the age groups were due to the effects of treatment, rather than due to natural
cognitive or physical aging.
Forced swim performance did not significantly differ between the treatment
groups. No differences were found at any Testing Session or Treatment Group for the
forced swim task, and the effect size was nominal; only 5% of the variability in forced
swim performance could be explained by treatment group membership. Again, it is
possible that the administered treatments did not alter the animals’ gut microbiomes as
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intended, which resulted in the probiotics unable to reestablish the gut microbiome with
commensal bacteria. It is also possible that the antibiotics did have an effect on reducing
the diversity of the gut microbiome, but the probiotic dosage was not strong enough to
replenish the diversity of the gut microbiome back to the organism’s baseline levels.
Interestingly, when comparing inactivity time to previous studies that utilized the forced
swim test in rats, animals in the present study spent much more time inactive compared
inactivity time reported in other research, however different rat strains were used (Hoban
et al., 2016).
Juvenile animals spent significantly more time inactive during the forced swim
task compared to the animals in the adult group, which was not in the hypothesized
direction. Age accounted for 34% of the variance in forced swim task performance. It is
possible that differences observed here were due, in part, to container differences used
during the task for young and old animals. Animals in the aged group were extensively
larger than animals in the juvenile condition, and required a larger container during the
forced swim task. Because of the size differences, older animals were forced to remain
more upright in the container, which may have impacted their ability to float and remain
immobile compared to the much smaller, juvenile age group.
Juvenile animals consumed significantly more water overall than the adult
animals. Because treatment was administered via drinking water, this difference affects
the dosage received by each age group. Consumption differences between age groups
were found for both antibiotic treatment and probiotic treatment, though effect sizes were
nominal (4% and 5% respectively), suggesting minimal practical significance in these
statistically observed differences. When collapsing across age of the animals, no
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significant differences were observed between animals that received antibiotic treatment
and animals that received sterile drinking water, but did significantly differ between
treatment groups for probiotic consumption. Animals that previously received prior
antibiotic treatment drank significantly more than the animals that had previously
received sterile drinking water, although the magnitude of the effect was nominal (3%).
It is possible that differences in taste between antibiotic water, probiotic water, and sterile
water affected the amount of consumption for some of the groups. Because the antibiotic
powder was a sodium salt mixture, it likely resulted in a more alkaline, bitter taste
compared to sterile drinking water. The difference in taste could account for the increase
in water consumption following the antibiotic treatment phase for animals that previously
received antibiotics compared to the animals that previously received sterile water.
Limitations
Although careful measures were taken to ensure design consistency and minimize
error, several limitations arose that may have impacted the study. A potential limitation
that may have contributed to the lack of effects is antibiotic and probiotic treatment time.
In the current study, antibiotic treatment lasted three weeks, which was selected as the
“middle ground,” based on previous results that utilized differing treatment times.
Specifically, behavioral effects following antibiotic administration were observed in as
few as two weeks (Guida et al., 2018), three weeks (Ceylani et al., 2018), and as long as
seven (Möhle et al., 2016) and 13 (Anukam, 2017) weeks. Behavioral effects following
probiotic treatment were observed in as little as two days (Möhle et al., 2016) and as long
as 11 weeks (Savignac et al., 2015). It is possible that the treatment times selected for the
study were not long enough to fully alter the gut microbiome. Additionally, older
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animals utilized in the study were not aged in the same facility where the study took
place. Therefore, the adult animals had their gut microbiomes largely established at
another facility, while the juvenile animals did not. It is possible that the differences
between these groups served to better protect, or impair their gut microbiome in response
to antibiotic insult.
In the originally proposed study, histological analyses were planned in order to
determine if altering the gut microbiome had an effect on the number of cells within the
subgranular zone of the dentate gyrus within the hippocampus. However, the cresyl
violet acetate stain did not target the nissl bodies of the neural cells as expected. Upon
deeper investigation, post-fixing a rat brain in 4% paraformaldehyde solution was
insufficient to fix the tissue. Although some studies found no significant differences in
tissue fixation and staining quality, these studies examined more superficial structures
and smaller tissue samples (Hare et al., 2014; Kasukurthi et al., 2009). For deeper and/or
larger structures, however, immersion fixation will not reach the internal structures of the
tissue (e.g., the dentate gyrus within the hippocampus) before hypoxia begins to change
tissue structure (Gage, Kipke, & Shain, 2012). These findings highlight the importance
of transcardial perfusion prior to histological staining to ensure best fixation practices.
Another limitation that might have had an effect on behavior might be that all
animals in the adult age condition were retired breeders, as that was the oldest age
attainable from any approved vendor. Previous research suggests that the aggressive
nature of Long Evans retired breeders is resultant from elevated corticosterone and
altered catecholamine levels (Patki et al., 2014), both of which can have an impact on
memory performance (Song, Che, Min-Wei, Murakami, & Matsumoto, 2006) and
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depressive-like behavior (Zangen, Overstreet, & Yadid, 1999). However, previous
studies comparing behavioral differences between retired breeders and aged virgin
animals did not find significant differences in the open field test, tightrope test, and
passive avoidance learning (Ingram, Spangler, & Vincent, 1983). Therefore, it is not
likely that observed differences between the age groups were the result of one group
previously used for breeding purposes. However, virgin adult rats would have been ideal
to compare to virgin juvenile rats.
Lastly, the current study attempted to utilize a better measure of spatial memory
performance in rats via the object location task. Previous literature that examined
behavioral effects of an altered the gut microbiome largely utilized the novel object
recognition task (Möhle et al., 2016; Magnusson et al., 2015); however, evidence
suggests that the hippocampus is imperative for object location, but not explicitly for
recognition memory (Barker & Waterburton, 2011; Broadbent, Squire, & Clark, 2004).
Although the dependency on the hippocampus is apparent in the object location task, it is
possible that the “study phase” was not long enough for the magnitude of the delay
between the study and test phase. The present study based the timing of the study phase
off of previous research that utilized a 5-minute study period (Gareau et al., 2011).
However, Ozawa, Yamada, and Ichitani (2011) found that a study phase of 20-minutes,
rather than 5-minute and 10-minute study sessions, yielded significant discrimination
indices after a 24-hour delay.
Future Directions
Future research should include a measure of fecal analysis in order to determine
whether antibiotics effectively eliminated the diversity, and probiotic administration
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effectively reestablished the commensal diversity of the gut microbiome of the animal.
This will ensure confidence that the gut microbiome was sufficiently altered, provide a
stronger link between any observed differences in behavioral and neural data, and help
aid future researchers in establishing an effective window for both antibiotic and
probiotics treatment periods. Researchers should also conduct transcardial perfusions
with paraformaldehyde in addition to 4% paraformaldehyde immersion fixation to
examine the direct effects of antibiotic and probiotic treatment on the hippocampus.
Perfusion fixation will prevent structural changes within the tissue following oxygen
depletion and reduce the likelihood of artifact (e.g., erythrocytes remaining in
vasculature) while staining. It is possible that treatment affected the hippocampus or
other brain structures, however those effects did not have sufficient time to produce
measurable behavioral changes. Future studies could include an additional age group to
incorporate pre-pubertal animals to further elucidate the possible effects of altering the
gut microbiome at various developmental periods throughout the lifespan. During the
data collection phase of the present study, multiple research assistants noticed drastic
behavior changes following antibiotic administration in only animals that received the
treatment while conducting daily health checks. Aggressive behavior and agitation
largely increased immediately following the start of antibiotic administration. Although
it’s anecdotal evidence, future projects that attempt to alter the gut microbiome using
antibiotics should consider including a measure of home cage behavior. Lastly, future
studies should attempt to determine whether a specific therapeutic dosage of both
antibiotics and probiotics is necessary in order to sufficiently alter the gut microbiome.
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These suggested lines of research will add to the rapidly growing body of literature
determined to provide a more direct link between gut flora diversity, the brain, and age.
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Table 1.
Descriptive Statistics for Object Location Performance for Treatment Group and Age
Baseline

Time 1

Juvenile
Group
Name
Naïve
No
Treatment
+
Probiotics
Antibiotics
+
Probiotics
Antibiotics
+ No
Treatment
Antibiotics
Onlya

Adult

Juvenile

Adult

Juvenile

Adult

N

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

10

12.75

21.40

19.75

40.26

35.15

27.73

22.35

12.78

17.03

10.64

22.09

17.65

3.92

21.62

10.71

11.30

59.24

7.86

10

18.38

9.39

18.95

14.19

52.41

3.24

0.32

19.71

3.07

13.36

23.72

3.88

6.81

21.11

-1.23

31.29

48.53

0.00

10

33.15

12.92

39.22

50.98

36.26

54.70

38.92

16.47

32.91

19.89

59.90

24.43

0.83

24.47

-1.13

-0.54

20.62

0.00

10

25.55

16.08

16.98

27.80

49.08

50.04

3.20

39.93

-9.67

14.23

20.37

7.21

0.67

15.95

-5.53

50.52

38.41

58.33

8

28.23

20.48

32.29

27.23

30.00

39.90

32.98

18.93

34.41

2.68

8.76

2.79

--

--

--

--

--

--

Note. Higher numbers indicate better object discrimination performance.
a

Time 2

Animals in this group were sacrificed prior to Time 2.
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Table 2.
Descriptive Statistics for Object Location Performance for Treatment Group and Age
Baseline

Time 1

Juvenile
Group
Name

Adult

Time 2

Juvenile

Adult

Juvenile

Adult

N

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

M

SD

Mdn

Naïve

10

105.29

42.64

134.58

65.61

52.44

49.27

130.60

54.62

154.40

46.06

46.61

21.09

123.12

46.05

145.66

42.20

44.37

32.44

No Treatment
+ Probiotics

10

93.27

37.50

101.25

80.75

58.14

87.55

126.84

45.36

117.10

65.68

73.39

41.81

90.26

10.60

92.30

65.46

98.63

22.41

Antibiotics +
Probiotics

10

106.91

35.94

111.05

39.50

13.53

37.17

86.63

41.54

99.05

46.30

38.80

34.88

96.13

62.35

96.20

37.68

51.19

12.84

Antibiotics +
No Treatment

10

106.63

59.09

126.47

42.33

52.52

21.05

122.63

59.80

100.56

20.12

13.50

15.35

97.90

71.18

70.08

16.01

14.37

11.78

Antibiotics
Only

7

89.95

58.74

66.78

26.60

24.86

24.26

102.72

93.34

106.71

54.48

91.01

10.31

--

--

--

--

--

--

Note. Time is represented in seconds.
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Table 3.
Mixed ANOVA for Age and Treatment Group on Object Location
Type III Sum of
Mean
Squares
df
Square

F

Sig.

Eta
Squared

Observed
Power

Testing Session**

11296.13

2

5648.07

5.15

0.008

0.14

0.81

Time x Group**

6751.29

6

1125.22

1.03

0.417

0.09

0.38

Time x Age**

813.97

2

406.98

0.37

0.690

0.01

0.11

Time x Group x Age**

9686.15

6

1614.36

1.47

0.200

0.12

0.53

Error**

70262.79

64

1097.86

Intercept

29930.11

1

29930.11

29.51

0.000

0.48

1.00

Treatment Group

6953.38

3

2317.79

2.29

0.098

0.18

0.52

Age

845.12

1

845.12

0.83

0.368

0.03

0.14

Group*Age

4140.91

3

1380.3

1.36

0.272

0.11

0.33

Error

32458.11

32

1014.32

** Repeated Measures Analyses.
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Table 4.
Mixed ANOVA for Age and Treatment Group on Forced Swim Test
Type III Sum of
Mean
Squares
df
Square
F
Testing Session**
2274.66
2
1137.33
1.77
Time x Group**
1612.86
6
268.81
0.42
Time x Age**
3454.75
2
1727.38
2.70
Time x Group x Age**
5616.00
6
936.00
1.46
Error**
41024.22
64
641.00
Intercept
715957.80
1
715957.80 109.89
Group
9805.04
3
3268.35
0.50
Age
107586.64
1
107586.64 16.51
Group*Age
10160.98
3
3386.99
0.52
Error
208495.32
32
6515.48
** Repeated Measures Analyses.

64

Sig.
0.178
0.864
0.075
0.206

Eta
Squared
0.05
0.04
0.08
0.12

Observed
Power
0.36
0.16
0.52
0.53

0.000
0.680
0.000
0.672

0.774
0.05
0.34
0.05

1.00
0.14
0.98
0.14
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Table 5.
Mixed ANOVA for Age and Treatment Group on Water Consumption at Time 1
Type III Sum of
Mean
Squares
df
Square
F
Sig.
Intercept

Eta
Squared

Observed
Power

93937.38

1

93937.38

2252.18

0.000

0.98

1.00

Group

206.27

4

51.57

1.24

0.311

0.11

0.35

Age

4456.93

1

4456.93

106.86

0.000

0.73

1.00

Group*Age

120.63

4

30.16

0.72

0.581

0.07

0.21

Error

1626.67

39

41.71

Total

102149.21

49
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Table 6.
Mixed ANOVA for Age and Treatment Group on Water Consumption at Time 2
Type III Sum of
Mean
Squares
df
Square
F
Sig.
Intercept
81431.29
1
81431.29
1345.37 0.000
Group
2885.74
3
961.91
15.89
0.000
Age
4274.56
1
4274.56
70.62
0.000
Group*Age
394.66
3
131.55
2.17
0.110
Error
1936.86
32
60.53
Total
90923.11
40

66

Eta
Squared
0.98
0.60
0.69
0.17

Observed
Power
1.00
1.00
1.00
0.50
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Naïve
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PBX
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ABX + No
TX
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No Treatment

Figure 1. Graphical depiction of the study timeline.
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Figure 2. Average antibiotic consumption per kilogram weight and Time 1 Forced Swim
Performance (N = 28). Antibiotic consumption spanned the three-week period between
Baseline forced swim test performance and Time 1 performance, β = 0.73, t(1) = 2.74, p
= .011, R2 = .23.
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Figure 3. Average antibiotic consumption per kilogram weight and Time 1 Object
Location Performance (N = 28). Antibiotic consumption spanned the three-week period
between baseline object location performance and Time 1 performance, β = 0.13, t(1) =
0.85, p = .402, R2 = .03.
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Figure 4. Age on antibiotic consumption per kilogram weight and Time 1 Object
Location Performance (N = 28). Antibiotic consumption spanned the three-week period
between baseline object location performance and Time 1 performance. Juveniles (β =
0.34, t(1) = 0.61, p = .555, R2 = .03) did not differ on object location performance
compared to adults (β = -1.03, t(1) = -0.95, p = .359, R2 = .07
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Figure 5. Age on antibiotic consumption per kilogram weight and Time 1 Forced Swim
Performance (N = 28). Antibiotic consumption spanned the three-week period between
Baseline forced swim test performance and Time 1 performance. Juvenile animals (β =
.11, t(1) = 0.10, p = .924, R2 = .00) did not differ from adults (β = -1.21, t(1) = -0.78, p =
.452, R2 = .05) on forced swim test inactivity.
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Figure 6. Average probiotic consumption per kilogram weight and Time 2 Forced Swim
Performance (N = 20) . Probiotic consumption spanned the one-week period between
Time 1 forced swim test and Time 2 forced swim test, β = 0.33, t(1) = 0.99, p = .334, R2
= .05.
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Figure 7. Average probiotic consumption per kilogram weight and Time 2 Object
Location Performance (N = 20). Probiotic consumption spanned the one-week period
between Time 1 object location test and Time 2 object location test, β = 0.15, t(1) = 0.90,
p = .379, R2 = .04.
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Figure 8. Age on probiotic consumption per kilogram weight and Time 2 Object
Location Performance (N = 20). Probiotic consumption spanned the one-week period
between Time 1 object location test and Time 2 object location test. Juveniles (β = -0.13,
t(1) = -0.71, p = .497, R2 = .06) did not differ compared to adult animals (β = 1.73, t(1) =
1.39, p = .203, R2 = .19).
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Figure 9. Age on probiotic consumption per kilogram weight and Time 2 Forced Swim
Performance at (N = 20). Probiotic consumption spanned the one-week period between
Time 1 forced swim test and Time 2 forced swim test. Juvenile animals (β = 0.15, t(1) =
0.42, p = .683, R2 = .02) did not differ from adult animals (β = -3.73, t(1) = -1.57, p =
.154, R2 = .24) on forced swim performance following probiotic treatment.

